Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings: A Meta-analysis

IMPORTANCE: Compared with the operating room (OR), office-based intravitreal injection (IVI) is considered a more cost-effective and convenient approach, yet clinical outcomes of IVIs with anti–vascular endothelial growth factor (VEGF) agents in different settings (office-based vs OR) have not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tong, Sun, Junran, Min, Jingyu, Zhou, Shuangwen, Zhu, Xiaolin, Jia, Huixun, Sun, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377608/
https://www.ncbi.nlm.nih.gov/pubmed/34410325
http://dx.doi.org/10.1001/jamaophthalmol.2021.3096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377608/
https://www.ncbi.nlm.nih.gov/pubmed/34410325
http://dx.doi.org/10.1001/jamaophthalmol.2021.3096

Ejemplares similares